Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
Greenberg
Arthur
A
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. arthur.greenberg@duke.edu
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D017483:Receptors, Vasopressin / Q000502:physiology; D000077602:Tolvaptan; D016896:Treatment Outcome
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D017483:Receptors, Vasopressin; D000077602:Tolvaptan